点击图片查看原图
份 库存999份
| 货号： | IPA1013-0001MG |
| 保存条件： | -20℃ |
| CAS号： | 35943-35-2 |
| 供应商： | 上海伟进生物科技有限公司 |
| 数量： | 10 |
| 英文名： | Triciribine(API-2) (Akt1,2,3 inhibitor) |
| 保质期： | 2 years |
| 规格： | 1mg |
Biological Activity
Triciribine (TCN) is a synthetic tricyclic nucleoside that is activated to its phosphate TCN-P by adenosine kinase and to inhibit cell growth, purine nucleotide synthesis, and incorporation of amino acids into proteins. In L1210 murine leukemic cells, TCN inhibits DNA synthesis through two mechanisms, either suppression of Okazaki fragment initiation or inhibition of the elongation of existing DNA chains. These two effects have different concentration responses [1-2]. TCN and TCN-P displays antiviral activity against a panel of HIV-1 and HIV-2 at IC50 values ranging from 0.02 to 0.46 μM [3]. Triciribine (API-2) selectively inhibits the phosphorylation and activation of Akt-1,-2 and -3, but does not directly suppress Akt kinase as well as known upstream activators of Akt including PI 3K and PDK1.API-2 potently inhibits Akt signaling in human tumor cells with aberrant Akt, leading to inhibition of cell growth and induction of apoptosis. In a xenograft nude mice model, API-2 significantly inhibits tumor growth in Akt-overexpressing cells but not in the tumors with low levels of Akt [4]. Phase I and II clinic trials of API-2 has been conducted on many advanced tumors, such as metastatic breast cancer [5].
Chemical Properties
| Cas No.: 35943-35-2 | M. Wt.: 320.31 |
| Formula: C13H16N6O4 | Purity: >98% |
| Synonym: TCN, Akt/PKB signaling inhibitor-2 (API-2), NSC 154020, tricyclic nucleoside | |
| Chemical Name: 1,5-Dihydro-5-methyl-1-β-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine | |
| Appearance: Pale yellow solid | |
| Solubility: Soluble in DMSO (30 mg/ml), sparingly soluble in water. | |
| Storage: Store powder at -20 ºC for the stability up to two years. | |
[VIP第1年] 指数:2
通过嘉定区市场监管局认证 
